ISBN: 9798185190722 - the abcs of primary aldosteronism: the complete clinical and patient resource for understanding hormonal hypertension and improving cardiovascular outcomes (6 resultados)

- Tapa blanda
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 25,41
Envío por EUR 35,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Taschenbuch. Condición: Neu. Neuware.

- Tapa blanda
- Impresión bajo demanda
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 19,20
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponible
Paperback. Condición: new. Paperback. Primary aldosteronism stands at a critical intersection of endocrinology, cardiovascular medicine, and public health yet for decades it has remained one of the most under-recognized and underdiagnosed causes of secondary hypertension worldwide. Traditionally considered a rare endocrine disorder, modern research has profoundly reshaped this perception, revealing primary aldosteronism not as an exception, but as a significant and often silent driver of high blood pressure, cardiovascular injury, and long-term organ damage.At its core, primary aldosteronism is a disorder of hormonal imbalance originating from the adrenal cortex, where excessive and autonomous secretion of aldosterone disrupts the body's delicate regulation of sodium, potassium, and fluid balance. This hormonal excess leads to persistent sodium retention, volume expansion, potassium depletion, and vascular remodeling-processes that collectively sustain hypertension and amplify cardiovascular risk far beyond that seen in essential hypertension alone. Importantly, this condition frequently occurs without obvious warning signs, and many individuals remain normokalemic, further masking its presence in routine clinical practice.Over the past two decades, advances in molecular biology, imaging techniques, and endocrine testing have transformed the understanding of primary aldosteronism from a niche diagnosis into a common, treatable, and potentially curable form of hypertension. It is now well established that a substantial proportion of patients with resistant hypertension-or even apparently uncomplicated hypertension may have an underlying aldosterone-driven pathology. Despite this, widespread under-screening persists, leading to missed opportunities for targeted therapy and preventable cardiovascular complications.This book is designed to bridge that gap between emerging scientific knowledge and practical clinical application. It provides a structured, accessible, and evidence-informed guide for clinicians, trainees, and patients seeking to understand the mechanisms, diagnosis, and management of this complex disorder.Rather than treating primary aldosteronism as a purely biochemical curiosity, this work emphasizes its real-world clinical impact how it contributes to stroke, myocardial remodeling, kidney dysfunction, and persistent treatment-resistant hypertension. It also highlights the importance of early recognition, appropriate biochemical screening, confirmatory testing, and subtype classification, all of which are essential for guiding individualized therapy, including mineralocorticoid receptor antagonists or curative surgical intervention in selected cases.Equally important, this book recognizes the patient perspective. A diagnosis of hormonal hypertension can be confusing and overwhelming, particularly when blood pressure appears resistant to conventional therapy. By translating complex endocrine concepts into clear, structured explanations, this resource aims to empower patients with knowledge, improve shared decision-making, and enhance long-term adherence to treatment strategies.Ultimately, primary aldosteronism is not merely a disease of excess hormone production it is a paradigm of preventable cardiovascular risk. With timely diagnosis and targeted treatment, many of its consequences can be reversed or significantly reduced. The goal of this book is to make that possibility more widely understood and more consistently achieved in both clinical practice and patient care. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

- Tapa blanda
- Impresión bajo demanda
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de AmericaPBShop.store US
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 19,21
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
PAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Tapa blanda
- Impresión bajo demanda
Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 18,47
Envío por EUR 2,69Se envía dentro de Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New. Print on Demand.

- Tapa blanda
- Impresión bajo demanda
Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 16,88
Envío por EUR 4,97Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
PAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Tapa blanda
- Impresión bajo demanda
Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 20,91
Envío por EUR 44,20Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponible
Paperback. Condición: new. Paperback. Primary aldosteronism stands at a critical intersection of endocrinology, cardiovascular medicine, and public health yet for decades it has remained one of the most under-recognized and underdiagnosed causes of secondary hypertension worldwide. Traditionally considered a rare endocrine disorder, modern research has profoundly reshaped this perception, revealing primary aldosteronism not as an exception, but as a significant and often silent driver of high blood pressure, cardiovascular injury, and long-term organ damage.At its core, primary aldosteronism is a disorder of hormonal imbalance originating from the adrenal cortex, where excessive and autonomous secretion of aldosterone disrupts the body's delicate regulation of sodium, potassium, and fluid balance. This hormonal excess leads to persistent sodium retention, volume expansion, potassium depletion, and vascular remodeling-processes that collectively sustain hypertension and amplify cardiovascular risk far beyond that seen in essential hypertension alone. Importantly, this condition frequently occurs without obvious warning signs, and many individuals remain normokalemic, further masking its presence in routine clinical practice.Over the past two decades, advances in molecular biology, imaging techniques, and endocrine testing have transformed the understanding of primary aldosteronism from a niche diagnosis into a common, treatable, and potentially curable form of hypertension. It is now well established that a substantial proportion of patients with resistant hypertension-or even apparently uncomplicated hypertension may have an underlying aldosterone-driven pathology. Despite this, widespread under-screening persists, leading to missed opportunities for targeted therapy and preventable cardiovascular complications.This book is designed to bridge that gap between emerging scientific knowledge and practical clinical application. It provides a structured, accessible, and evidence-informed guide for clinicians, trainees, and patients seeking to understand the mechanisms, diagnosis, and management of this complex disorder.Rather than treating primary aldosteronism as a purely biochemical curiosity, this work emphasizes its real-world clinical impact how it contributes to stroke, myocardial remodeling, kidney dysfunction, and persistent treatment-resistant hypertension. It also highlights the importance of early recognition, appropriate biochemical screening, confirmatory testing, and subtype classification, all of which are essential for guiding individualized therapy, including mineralocorticoid receptor antagonists or curative surgical intervention in selected cases.Equally important, this book recognizes the patient perspective. A diagnosis of hormonal hypertension can be confusing and overwhelming, particularly when blood pressure appears resistant to conventional therapy. By translating complex endocrine concepts into clear, structured explanations, this resource aims to empower patients with knowledge, improve shared decision-making, and enhance long-term adherence to treatment strategies.Ultimately, primary aldosteronism is not merely a disease of excess hormone production it is a paradigm of preventable cardiovascular risk. With timely diagnosis and targeted treatment, many of its consequences can be reversed or significantly reduced. The goal of this book is to make that possibility more widely understood and more consistently achieved in both clinical practice and patient care. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…